Year archive

Shenzhen Hepalink Pharmaceutical Group Co., Ltd. — 2025 filings

All 68 regulatory filings released by Shenzhen Hepalink Pharmaceutical Group Co., Ltd. (9989) in 2025, sourced directly from the official regulator.

68 Filings

2025 Period

2025 filings (68)

Filing	Released	Lang
ARTICLES OF ASSOCIATION Governance Information	2025-12-17	English
An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section Regulatory Filings	2025-12-16	English
An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section Regulatory Filings	2025-12-16	English
LIST OF DIRECTORS AND THEIR ROLES AND FUNCTIONS Governance Information	2025-12-16	English
POLL RESULTS OF THE 2025 FIRST EXTRAORDINARY GENERAL MEETING HELD ON DECEMBER 16, 2025 Declaration of Voting Results & Voting Rights Announcements	2025-12-16	English
An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section Regulatory Filings	2025-12-05	English
An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section Regulatory Filings	2025-12-05	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 November 2025 Regulatory Filings	2025-12-01	English
FOR THE 2025 FIRST EXTRAORDINARY GENERAL MEETING TO BE HELD ON TUESDAY, DECEMBER 16, 2025 Proxy Solicitation & Information Statement	2025-11-24	English
NOTICE OF THE 2025 FIRST EXTRAORDINARY GENERAL MEETING Proxy Solicitation & Information Statement	2025-11-24	English
(1) PROPOSED ABOLITION OF THE SUPERVISORY COMMITTEE, PROPOSED AMENDMENTS TO THE ARTICLES AND PROPOSED AMENDMENTS TO THE RELATED RULES OF PROCEDURES OF THE COMPANY; (2) PROPOSED AMENDMENTS TO CERT Proxy Solicitation & Information Statement	2025-11-24	English
(1) PROPOSED ABOLITION OF THE SUPERVISORY COMMITTEE AND THE PROPOSED AMENDMENTS TO THE ARTICLES RELATED RULES OF PROCEDURES OF THE COMPANY AND CERTAIN INTERNAL CORPORATE GOVERNANCE MEASURES OF THE COM Board/Management Information	2025-11-24	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 October 2025 Regulatory Filings	2025-11-03	English
2025 THIRD QUARTERLY REPORT Interim / Quarterly Report 9M 2025	2025-10-30	English
DATE OF BOARD MEETING Regulatory Filings	2025-10-17	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 September 2025 Regulatory Filings	2025-10-03	English
2025 INTERIM REPORT Interim / Quarterly Report H1 2025	2025-09-18	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 August 2025 Regulatory Filings	2025-09-02	English
INTERIM RESULTS ANNOUNCEMENT FOR THE SIX MONTHS ENDED JUNE 30, 2025 Interim / Quarterly Report H1 2025	2025-08-29	English
DATE OF BOARD MEETING Regulatory Filings	2025-08-15	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 July 2025 Regulatory Filings	2025-08-04	English
VOLUNTARY ANNOUNCEMENT - H1710 INJECTION HAS ENROLLED THE FIRST SUBJECT AND COMPLETED THE FIRST DOSING IN THE PHASE 1 CLINICAL TRIAL Regulatory Filings	2025-07-18	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 June 2025 Regulatory Filings	2025-07-02	English
An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section Regulatory Filings	2025-06-27	English
FINAL DIVIDEND FOR THE YEAR ENDED 31 DECEMBER 2024 (UPDATED) Notice of Dividend Amount	2025-06-23	English
VOLUNTARY ANNOUNCEMENT - ENOXAPARIN SODIUM INJECTION OBTAINS NEW MANUFACTURER AUTHORIZATION FROM EMA Regulatory Filings	2025-06-17	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 May 2025 Share Issue/Capital Change	2025-06-02	English
FINAL DIVIDEND FOR THE YEAR ENDED 31 DECEMBER 2024 (UPDATED) Notice of Dividend Amount	2025-05-22	English
POLL RESULTS OF THE 2024 ANNUAL GENERAL MEETING HELD ON MAY 22, 2025 Declaration of Voting Results & Voting Rights Announcements	2025-05-22	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 April 2025 Regulatory Filings	2025-05-02	English
NOTICE OF THE 2024 ANNUAL GENERAL MEETING Proxy Solicitation & Information Statement	2025-04-30	English
PROXY FORM FOR THE 2024 ANNUAL GENERAL MEETING TO BE HELD ON THURSDAY, MAY 22, 2025 (OR ANY ADJOURNMENT THEREOF) Proxy Solicitation & Information Statement	2025-04-30	English
2024 AGM Circular Proxy Solicitation & Information Statement	2025-04-30	English
2024 Environmental, Social and Governance Report Regulatory Filings	2025-04-30	English
2024 Annual Report Regulatory Filings	2025-04-30	English
VOLUNTARY ANNOUNCEMENT - "IVENOXIN" OBTAINS APPROVAL FROM SOUTH AFRICA Regulatory Filings	2025-04-24	English
An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section Regulatory Filings	2025-04-24	English
VOLUNTARY ANNOUNCEMENT - "IVENOXIN" OBTAINS APPROVAL FROM SOUTH AFRICA Regulatory Filings	2025-04-24	English
2025 FIRST QUARTERLY REPORT Interim / Quarterly Report Q1 2025	2025-04-24	English
DATE OF BOARD MEETING Report Publication Announcement	2025-04-10	English
An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section Regulatory Filings	2025-04-02	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 March 2025 Regulatory Filings	2025-04-02	English
LIST OF DIRECTORS AND THEIR ROLES AND FUNCTIONS Board/Management Information	2025-03-31	English
CHANGE IN COMPOSITION OF THE NOMINATION COMMITTEE Board/Management Information	2025-03-31	English
FINAL DIVIDEND FOR THE YEAR ENDED 31 DECEMBER 2024 Notice of Dividend Amount	2025-03-28	English
An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section Regulatory Filings	2025-03-28	English
An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section Regulatory Filings	2025-03-28	English
An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section Regulatory Filings	2025-03-28	English
An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section Regulatory Filings	2025-03-28	English
An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section Regulatory Filings	2025-03-28	English
An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section Regulatory Filings	2025-03-28	English
An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section Regulatory Filings	2025-03-28	English
An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section Regulatory Filings	2025-03-28	English
An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section Regulatory Filings	2025-03-28	English
An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section Regulatory Filings	2025-03-28	English
An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section Regulatory Filings	2025-03-28	English
An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section Regulatory Filings	2025-03-28	English
An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section Regulatory Filings	2025-03-28	English
ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED DECEMBER 31, 2024 Earnings Release FY 2024	2025-03-28	English
DATE OF BOARD MEETING Report Publication Announcement	2025-03-14	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 28 February 2025 Regulatory Filings	2025-03-04	English
VOLUNTARY ANNOUNCEMENT - "ENOPARIN" OBTAINS APPROVAL FROM ARGENTINA Regulatory Filings	2025-02-26	English
VOLUNTARY ANNOUNCEMENT - H1710 INJECTION RECEIVED THE NOTICE OF APPROVAL FOR CLINICAL TRIAL FROM NMPA Regulatory Filings	2025-02-18	English
VOLUNTARY ANNOUNCEMENT - OBTAINING THE GMP CERTIFICATE FROM EMA Regulatory Filings	2025-02-14	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 January 2025 Regulatory Filings	2025-02-05	English
POSITIVE PROFIT ALERT ANNOUNCEMENT FOR THE ESTIMATED 2024 ANNUAL RESULTS Earnings Release FY 2024	2025-01-24	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 December 2024 Regulatory Filings	2025-01-03	English
VOLUNTARY ANNOUNCEMENT - ENTERING INTO DISTRIBUTION AGREEMENT WITH YONGTAI PHARMACEUTICAL Regulatory Filings	2025-01-02	English